The IMCAS Congress  represents one of the leading international meetings dedicated to aesthetic medicine, dermatology, and plastic surgery, bringing together every year in Paris thousands of specialists from around the world to discuss the latest scientific and technological developments in the field. In 2026, numerous members of the Scientific Committee of Agorà – Italian Society of Aesthetic Medicine  also attended the congress, contributing to the international scientific

What really happens in the dermis? One of the most relevant advances in recent scientific literature concerns the increasingly precise understanding of the biological dynamics of tattoo pigment. Contrary to the intuitive assumption that ink remains statically “deposited” in the skin, histological evidence demonstrates that tattoo pigment localizes within the dermis, where it is primarily engulfed by dermal macrophages and fibroblasts¹. This point is fundamental: tattoos do no

Commentary on the Article "Hyaluronic Acid Fillers and ASIA Syndrome: Case Studies” ASIA syndrome (Autoimmune/Inflammatory Syndrome Induced by Adjuvants), first described in 2011 by Professor Yehuda Schoenfeld, encompasses a group of clinical conditions in which the immune response is excessively modulated by substances with an adjuvant role—that is, molecules capable of enhancing the immune response without acting as direct antigens. These substances directly interfere with

L’articolo offre una revisione approfondita sull’impiego della ialuronidasi in medicina estetica, con particolare attenzione alle formulazioni disponibili, agli aspetti di sicurezza e alla pratica clinica. La ialuronidasi rappresenta uno strumento utile nella gestione delle complicanze correlate ai filler a base di acido ialuronico, quali ipercorrezioni, noduli ed eventi vascolari. L’analisi evidenzia un’ampia variabilità nelle modalità di utilizzo e una carenza di protocolli

L’articolo offre una revisione approfondita sull’impiego della ialuronidasi in medicina estetica, con particolare attenzione alle formulazioni disponibili, agli aspetti di sicurezza e alla pratica clinica. La ialuronidasi rappresenta uno strumento utile nella gestione delle complicanze correlate ai filler a base di acido ialuronico, quali ipercorrezioni, noduli ed eventi vascolari. L’analisi evidenzia un’ampia variabilità nelle modalità di utilizzo e una carenza di protocolli

Milano-Cortina 2026: in montagna la performance passa anche dalla pelle. Raggi UV, freddo e vento richiedono idratazione e fotoprotezione mirate.

Milan–Cortina 2026: in the mountains, performance also depends on skin health. UV radiation, cold and wind require targeted hydration and photoprotection.

Scientific research represents one of the fundamental pillars for the advancement of medicine and for the tangible improvement of prevention, diagnosis, and treatment of oncological diseases. Within this framework lies the long-standing commitment of Agorà for Scientific Research , which since 2020 has been funding an annual research fellowship in collaboration with Fondazione Umberto Veronesi ETS . Bearing witness to the value of this shared path, Professor Paolo Veronesi ex

Pediatric Dermocosmetics: Agorà Calls for Responsibility in the Use of Cosmetics for Minors and Highlights the Importance of Age-Appropriate Skincare Routines Agorà – the Italian Society of Aesthetic Medicine – draws attention to an issue of growing clinical and social relevance: the use of dermocosmetic products from an early age. Increased exposure to digital content and adult-oriented beauty trends is driving a progressively earlier and not always appropriate adoption of s

Patient safety is a fundamental pillar in modern aesthetic medicine. The Integrated BLSD Course for Aesthetic Physicians, organized by Agorà – Italian Scientific Society of Aesthetic Medicine, was designed to provide professionals in the sector with the skills necessary to manage health emergencies in outpatient or office settings. During the training day, participants explored: early recognition of the signs and symptoms of medical emergencies; standardized intervention prot

In recent months, there has been growing interest in GLP-1 (Glucagon-Like Peptide-1) receptor agonist medications , used in the medical setting for the treatment of type 2 diabetes and, in specific formulations and dosages, for the pharmacological management of obesity ³,⁴. These molecules, analogues of endogenous GLP-1, act by modulating hormonal and neuroendocrine pathways involved in the regulation of glucose metabolism and appetite, producing favorable effects on glycemi